Activation and activities of the p53 tumour suppressor protein

被引:241
作者
Bálint, É [1 ]
Vousden, KH [1 ]
机构
[1] NCI Frederick, Frederick, MD 21702 USA
关键词
D O I
10.1054/bjoc.2001.2128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 tumour suppressor protein inhibits malignant progression by mediating cell cycle arrest, apoptosis or repair following cellular stress. One of the major regulators of p53 function is the MDM2 protein, and multiple forms of cellular stress activate p53 by inhibiting the MDM2-mediated degradation of p53. Mutations in p53, or disruption of the pathways that allow activation of p53, seem to be a general feature of all cancers. Here we review recent advances in our understanding of the pathways that regulate p53 and the pathways that are induced by p53, as well as their implications for cancer therapy. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:1813 / 1823
页数:11
相关论文
共 215 条
  • [51] JNK targets p53 ubiquitination and degradation in nonstressed cells
    Fuchs, SY
    Adler, V
    Buschmann, T
    Yin, ZM
    Wu, XW
    Jones, SN
    Ronai, Z
    [J]. GENES & DEVELOPMENT, 1998, 12 (17) : 2658 - 2663
  • [52] Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo
    Gaiddon, C
    Moorthy, NC
    Prives, C
    [J]. EMBO JOURNAL, 1999, 18 (20) : 5609 - 5621
  • [53] The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control
    Garkavtsev, I
    Grigorian, IA
    Ossovskaya, VS
    Chernov, MV
    Chumakov, PM
    Gudkov, AV
    [J]. NATURE, 1998, 391 (6664) : 295 - 298
  • [54] The MDM2 RING-finger domain is required to promote p53 nuclear export
    Geyer, RK
    Yu, ZK
    Maki, CG
    [J]. NATURE CELL BIOLOGY, 2000, 2 (09) : 569 - 573
  • [55] Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
    Gostissa, M
    Hengstermann, A
    Fogal, V
    Sandy, P
    Schwarz, SE
    Scheffner, M
    Del Sal, G
    [J]. EMBO JOURNAL, 1999, 18 (22) : 6462 - 6471
  • [56] DOWN-REGULATION OF WILD-TYPE P53 ACTIVITY INTERFERES WITH APOPTOSIS OF IL-3-DEPENDENT HEMATOPOIETIC-CELLS FOLLOWING IL-3 WITHDRAWAL
    GOTTLIEB, E
    HAFFNER, R
    VONRUDEN, T
    WAGNER, EF
    OREN, M
    [J]. EMBO JOURNAL, 1994, 13 (06) : 1368 - 1374
  • [57] Identification of a CK2 phosphorylation site in mdm2
    Götz, C
    Kartarius, S
    Scholtes, P
    Nastainczyk, W
    Montenarh, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (02): : 493 - 501
  • [58] p300/MDM2 complexes participate in MDM2-mediated p53 degradation
    Grossman, SR
    Perez, M
    Kung, AL
    Joseph, M
    Mansur, C
    Xiao, ZX
    Kumar, S
    Howley, PM
    Livingston, DM
    [J]. MOLECULAR CELL, 1998, 2 (04) : 405 - 415
  • [59] Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
    Gu, W
    Roeder, RG
    [J]. CELL, 1997, 90 (04) : 595 - 606
  • [60] The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation
    Guerra, B
    Gotz, C
    Wagner, P
    Montenarh, M
    Issinger, OG
    [J]. ONCOGENE, 1997, 14 (22) : 2683 - 2688